Peripheral CD5+ B cells in antineutrophil cytoplasmic antibody-associated vasculitis.

Unizony, Sebastian

Peripheral CD5+ B cells in antineutrophil cytoplasmic antibody-associated vasculitis. [electronic resource] - Arthritis & rheumatology (Hoboken, N.J.) Feb 2015 - 535-44 p. digital

Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

2326-5205

10.1002/art.38916 doi


Adult
Aged
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis--drug therapy
Antibodies, Monoclonal, Murine-Derived--therapeutic use
Antirheumatic Agents--therapeutic use
Azathioprine--therapeutic use
B-Lymphocytes--immunology
Biomarkers
CD5 Antigens--metabolism
Cell Count
Cyclophosphamide--therapeutic use
Disease Progression
Double-Blind Method
Drug Therapy, Combination
Female
Humans
Male
Middle Aged
Rituximab
Treatment Outcome